logo-loader
Pivot Pharmaceuticals

Full interview: Pivot Pharmaceutical sign Letter of Intent for controlling interest in iAmHealth

Pivot Pharmaceuticals (CSE: PVOT-OTC-PVOTF) President Russell Starr sat down with Steve Darling from Proactive Vancouver to discuss their company that plays in the cannabis. Starr is discussing how the company has changed including their very influential leaders. 

Starr also told Proactive about their current sales in Europe and when they will be in Canada and the U.S. with a number of different lines including pets and sexual health. Starr also shares details about a new deal they just signed with iAmHealth.

Quick facts: Pivot Pharmaceuticals

Price: $0.29

Market: CSE
Market Cap: $49.6 m
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

Full interview: Alchemist sees big market in China for medical cannabis sales

Alchemist (CSE: AMS) CEO Paul Mann and Vice President of Business Development, Asia Pacific Johnson Lee joined Steve Darling from Proactive Vancouver to discuss Alchemist looking for opportunities for cannabis in the emerging cannabis market.  Mann and Lee talk about what the industry...

6 hours, 37 minutes ago

2 min read